US Patent Issued to VitalTE LifeSciences on Aug. 18 for "Method of administering a hormone encapsulated by a hydrogel with a dual chamber syringe" (Nevada, Kansas Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,605, issued on Aug. 18, was assigned to VitalTE LifeSciences Inc. (Reno, Nev.).

"Method of administering a hormone encapsulated by a hydrogel with a dual chamber syringe" was invented by Charles P. Virden (Reno, Nev.), Stephen Harrington (Overland Park, Kan.) and Stella Vnook (Reno, Nev.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for administering a hormone encapsulated by a hydrogel polymer with a dual chamber syringe is described. The method includes providing a crosslinked methacrylate hyaluronic acid (MHA) polymer that encapsulates a hormone. The crosslinked MHA polymer is the hydrogel polymer. A dosage of the crosslinked MHA polyme...